1. Home
  2. ORBS vs TARA Comparison

ORBS vs TARA Comparison

Compare ORBS & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eightco Holdings Inc.

ORBS

Eightco Holdings Inc.

HOLD

Current Price

$0.73

Market Cap

262.0M

Sector

N/A

ML Signal

HOLD

Logo Protara Therapeutics Inc.

TARA

Protara Therapeutics Inc.

HOLD

Current Price

$3.94

Market Cap

236.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ORBS
TARA
Founded
1966
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
262.0M
236.1M
IPO Year
2022
2014

Fundamental Metrics

Financial Performance
Metric
ORBS
TARA
Price
$0.73
$3.94
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$24.40
AVG Volume (30 Days)
11.9M
374.8K
Earning Date
04-14-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
38.25
EPS
N/A
N/A
Revenue
$31,820,779.00
$2,948,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.57
$2.97
52 Week High
$15.96
$7.82

Technical Indicators

Market Signals
Indicator
ORBS
TARA
Relative Strength Index (RSI) 55.04 43.60
Support Level $0.58 $3.72
Resistance Level $0.96 $4.20
Average True Range (ATR) 0.05 0.17
MACD 0.02 -0.00
Stochastic Oscillator 80.21 34.42

Price Performance

Historical Comparison
ORBS
TARA

About ORBS Eightco Holdings Inc.

Eightco Holdings Inc operates in Forever 8 Inventory Cash Flow Solution. The company is a dynamic technology-focused company committed to driving growth and innovation through strategic acquisitions and management. Forever 8 focuses on purchasing inventory for e-commerce retailers and is part of its Inventory Solution Business. Corrugated Packaging Business manufactured and sold custom packaging for a wide products and through packaging helps customers generate brand awareness and promote brand image. Generate the substantial majority of revenues from inventory financing and inventory management services.

About TARA Protara Therapeutics Inc.

Protara Therapeutics Inc is a clinical-stage biopharmaceutical company focused on advancing its therapies for the treatment of cancer and rare diseases. Its drug development pipeline includes: TARA-002, an investigational cell therapy in development for the treatment of non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs); and IV Choline Chloride, an investigational phospholipid substrate replacement therapy, for patients receiving parenteral support, or PS, which includes both nutrition and fluids.

Share on Social Networks: